US FDA sets new template for non-lab COVID-19 diagnostic test developers
New recommendations aim to help get tests to market that are simple enough to use at home, similar to a pregnancy test
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Emergency Use Authorisation
Cipla launches Cipremi to treat severe COVID-19 disease
The drug is the only US FDA approved Emergency Use Authorisation (EUA) treatment for patients with severe COVID-19 disease…
FDA issues EUA for Abbott’s Alinity m molecular laboratory instrument
The automated platform can run more tests in less time to give laboratories improved efficiency, flexibility when using the…
Abbott launches third COVID-19 test
A lab-based serology blood test for detection of antibody, IgG, that identifies if a person has had COVID-19
US FDA issues EUA for molecular point-of-care test for detection of COVID-19 by Abbot
The test will run on company's ID NOW platform, providing rapid results in a wide range of healthcare settings